(Bloomberg) -- Amgen Inc., the world's largest
biotechnology company, and drug retailer CVS Caremark Corp. led
borrowers selling $34 billion of bonds this week as issuance
accelerated on signs the economy is improving.
The sales pushed the total for May to $128.6 billion,
making this month the second-busiest ever, according to data
compiled by Bloomberg. Thousand Oaks, California-based Amgen
issued $4 billion of notes to buy back stock, and CVS offered
$5.5 billion in the biggest investment-grade sale this year.
Read more at Bloomberg Bonds News
biotechnology company, and drug retailer CVS Caremark Corp. led
borrowers selling $34 billion of bonds this week as issuance
accelerated on signs the economy is improving.
The sales pushed the total for May to $128.6 billion,
making this month the second-busiest ever, according to data
compiled by Bloomberg. Thousand Oaks, California-based Amgen
issued $4 billion of notes to buy back stock, and CVS offered
$5.5 billion in the biggest investment-grade sale this year.
Read more at Bloomberg Bonds News
No comments:
Post a Comment